Literature DB >> 17965185

Atomic-resolution crystal structure of the antiviral lectin scytovirin.

Tinoush Moulaei1, Istvan Botos, Natasza E Ziółkowska, Heidi R Bokesch, Lauren R Krumpe, Tawnya C McKee, Barry R O'Keefe, Zbigniew Dauter, Alexander Wlodawer.   

Abstract

The crystal structures of the natural and recombinant antiviral lectin scytovirin (SVN) were solved by single-wavelength anomalous scattering and refined with data extending to 1.3 A and 1.0 A resolution, respectively. A molecule of SVN consists of a single chain 95 amino acids long, with an almost perfect sequence repeat that creates two very similar domains (RMS deviation 0.25 A for 40 pairs of Calpha atoms). The crystal structure differs significantly from a previously published NMR structure of the same protein, with the RMS deviations calculated separately for the N- and C-terminal domains of 5.3 A and 3.7 A, respectively, and a very different relationship between the two domains. In addition, the disulfide bonding pattern of the crystal structures differs from that described in the previously published mass spectrometry and NMR studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17965185      PMCID: PMC2222830          DOI: 10.1110/ps.073157507

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  11 in total

1.  Automated protein model building combined with iterative structure refinement.

Authors:  A Perrakis; R Morris; V S Lamzin
Journal:  Nat Struct Biol       Date:  1999-05

2.  A potent novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.

Authors:  Heidi R Bokesch; Barry R O'Keefe; Tawnya C McKee; Lewis K Pannell; Gregory M L Patterson; Roberta S Gardella; Raymond C Sowder; Jim Turpin; Karen Watson; Robert W Buckheit; Michael R Boyd
Journal:  Biochemistry       Date:  2003-03-11       Impact factor: 3.162

3.  Substructure solution with SHELXD.

Authors:  Thomas R Schneider; George M Sheldrick
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2002-09-28

4.  MOLPROBITY: structure validation and all-atom contact analysis for nucleic acids and their complexes.

Authors:  Ian W Davis; Laura Weston Murray; Jane S Richardson; David C Richardson
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

5.  Refinement of macromolecular structures by the maximum-likelihood method.

Authors:  G N Murshudov; A A Vagin; E J Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1997-05-01

6.  Free R value: a novel statistical quantity for assessing the accuracy of crystal structures.

Authors:  A T Brünger
Journal:  Nature       Date:  1992-01-30       Impact factor: 49.962

7.  Potent anti-HIV activity of scytovirin domain 1 peptide.

Authors:  Changyun Xiong; Barry R O'Keefe; R Andrew Byrd; James B McMahon
Journal:  Peptides       Date:  2006-05-02       Impact factor: 3.750

8.  Overexpression and purification of scytovirin, a potent, novel anti-HIV protein from the cultured cyanobacterium Scytonema varium.

Authors:  Changyun Xiong; Barry R O'Keefe; Istvan Botos; Alexander Wlodawer; James B McMahon
Journal:  Protein Expr Purif       Date:  2005-10-24       Impact factor: 1.650

9.  Novel approach to phasing proteins: derivatization by short cryo-soaking with halides.

Authors:  Z Dauter; M Dauter; K R Rajashankar
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2000-02

10.  The novel fold of scytovirin reveals a new twist for antiviral entry inhibitors.

Authors:  Robert L McFeeters; Changyun Xiong; Barry R O'Keefe; Heidi R Bokesch; James B McMahon; Daniel M Ratner; Riccardo Castelli; Peter H Seeberger; R Andrew Byrd
Journal:  J Mol Biol       Date:  2007-03-20       Impact factor: 5.469

View more
  18 in total

1.  The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.

Authors:  Kabamba B Alexandre; Elin S Gray; Hazel Mufhandu; James B McMahon; Ereck Chakauya; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2011-12-29       Impact factor: 3.616

2.  Topology of the disulfide bonds in the antiviral lectin scytovirin.

Authors:  Tinoush Moulaei; Olga Stuchlik; Matthew Reed; Weirong Yuan; Jan Pohl; Wuyuan Lu; Lauren Haugh-Krumpe; Barry R O'Keefe; Alexander Wlodawer
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

3.  Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin.

Authors:  Kabamba B Alexandre; Elin S Gray; Bronwen E Lambson; Penny L Moore; Isaac A Choge; Koleka Mlisana; Salim S Abdool Karim; James McMahon; Barry O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2010-04-13       Impact factor: 3.616

4.  Mechanisms of HIV-1 subtype C resistance to GRFT, CV-N and SVN.

Authors:  Kabamba B Alexandre; Penny L Moore; Molati Nonyane; Elin S Gray; Nthabeleng Ranchobe; Ereck Chakauya; James B McMahon; Barry R O'Keefe; Rachel Chikwamba; Lynn Morris
Journal:  Virology       Date:  2013-08-15       Impact factor: 3.616

Review 5.  Biomedical Applications of Biosynthesized Gold Nanoparticles from Cyanobacteria: an Overview.

Authors:  Chinmayee Priyadarsani Mandhata; Chita Ranjan Sahoo; Rabindra Nath Padhy
Journal:  Biol Trace Elem Res       Date:  2022-01-27       Impact factor: 4.081

Review 6.  Antiviral lectins as potential HIV microbicides.

Authors:  Leonardus M I Koharudin; Angela M Gronenborn
Journal:  Curr Opin Virol       Date:  2014-07-08       Impact factor: 7.090

7.  Intrinsically semi-disordered state and its role in induced folding and protein aggregation.

Authors:  Tuo Zhang; Eshel Faraggi; Zhixiu Li; Yaoqi Zhou
Journal:  Cell Biochem Biophys       Date:  2013       Impact factor: 2.194

8.  Monomerization of viral entry inhibitor griffithsin elucidates the relationship between multivalent binding to carbohydrates and anti-HIV activity.

Authors:  Tinoush Moulaei; Shilpa R Shenoy; Barbara Giomarelli; Cheryl Thomas; James B McMahon; Zbigniew Dauter; Barry R O'Keefe; Alexander Wlodawer
Journal:  Structure       Date:  2010-09-08       Impact factor: 5.006

9.  Antiviral lectins from red and blue-green algae show potent in vitro and in vivo activity against hepatitis C virus.

Authors:  Yutaka Takebe; Carrie J Saucedo; Garry Lund; Rie Uenishi; Saiki Hase; Takayo Tsuchiura; Norman Kneteman; Koreen Ramessar; D Lorne J Tyrrell; Masayuki Shirakura; Takaji Wakita; James B McMahon; Barry R O'Keefe
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

Review 10.  Algal lectins as potential HIV microbicide candidates.

Authors:  Dana Huskens; Dominique Schols
Journal:  Mar Drugs       Date:  2012-07-10       Impact factor: 6.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.